Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis
{{output}}
Objective: To synthesize adverse event (AE) data from randomized controlled trials (RCTs) of levetiracetam (LEV) and brivaracetam (BRV), compare their safety profiles, and identify moderators of AE risk. ... ...
